The burgeoning landscape of novel treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual mechanism agonists targeting the GLP-1 and GIP receptors. While sharing a similar https://minamuuo585541.wikilentillas.com/1965164/retatrutide_vs_tirzepatide_a_comparative_analysis